Intrinsiqq
iShares Genomics Immunology and Healthcare ETF logo

iShares Genomics Immunology and Healthcare ETF

IDNAETF · NYSE Arca

$37.00

-$0.81 (-2.14%)

EOD Nov 20, 2026

Compare IDNA with another ETF

Key facts

Expense ratio
0.47%
Dividend yield (TTM)
0.76%
Distributions
Semi-annual
Fund net assets (Jul 2026)
$191M
Stocks held
50
Other positions
12
Turnover (last fiscal year)
52%
52-week range
$24.29 to $43.79

Top 10 holdings

All holdings

50.8% of assets in ten stocks, as of Oct 28, 2026

IDNA top 10 holdings by weight
CompanyWeightQuality
Moderna, Inc.MRNA12.17%13
Twist Bioscience CorporationTWST6.75%40
GEGenmabGMAB6.30%n/a
Iovance Biotherapeutics, Inc.IOVA4.86%10
Caris Life Sciences, Inc.CAI3.67%71
TATakeda Pharmaceutical45023.49%n/a
Regeneron Pharmaceuticals, Inc.REGN3.45%54
Revolution Medicines Inc.RVMD3.41%10
Exelixis Inc.EXEL3.39%98
Bayer AGBAYN.XETR3.31%32

Sector allocation

Share of the fund's assets

  • Healthcare79.4%
  • Health Care16.6%
  • Industrials3.8%

Scores of what it owns

Every holding's score

Each holding's score, weighted by its size in the fund

33Qualityout of 10010Dividendout of 100

4% of the fund's stock weight sits in companies with a Quality score above 75, 69% in companies below 50.

Where it invests

Stock weight by the company's home country

  • United States66.4%
  • Denmark6.3%
  • Germany6.0%
  • France5.4%
  • Japan5.0%
  • Switzerland3.1%
  • Canada2.7%
  • United Kingdom2.5%

And 2 more countries.

Growth of $10,000

With and without the dividends reinvested

IDNA pays semi-annual. Over the last twelve months it paid $0.28 per share, a 0.76% yield at today's price. The latest payment was $0.13, ex-dividend Jun 15, 2026.

Average annual returns

Total return at net asset value, to Jul 31, 2026, as reported to the SEC

IDNA average annual total returns
1 year5 years10 years
54.25%7.47%4.87%

Past returns say nothing certain about future ones.

IDNA questions

What does IDNA invest in?+

iShares Genomics Immunology and Healthcare ETF is an exchange-traded fund. Its largest holdings are Moderna, Inc. (12.17%), Twist Bioscience Corporation (6.75%), Genmab (6.30%).

What is IDNA's expense ratio?+

0.47% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $47.00 a year.

How much does IDNA pay in dividends?+

IDNA paid $0.28 per share over the last twelve months, a 0.76% yield at the Nov 20, 2026 close of $37.00. It pays semi-annual.

How good are the companies IDNA owns?+

Weighted by position size, the stocks in IDNA average a Quality score of 33 out of 100. 4% of the fund's stock weight sits in companies scoring above 75, 69% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.

More on IDNA: Holdings · Dividend history

Holdings: the fund's own holdings list, published by BlackRock iShares, as of Oct 28, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to Jul 31, 2026. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Nov 20, 2026.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.